1.02
Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
53.33%
0.105
|
0.225 | - | - | - |
| Operating Expenses |
27.43%
3.289
|
2.581 | 2.481 | 2.089 | 2.108 |
| Depreciation and Amortization |
0.00%
0.012
|
0.012 | 0.013 | 0.013 | 0.021 |
| Operating Income/Loss |
35.14%
-3.184
|
-2.356 | -2.481 | -2.089 | -2.108 |
| Nonoperating Income/Loss |
64.91%
0.02
|
0.057 | 0.055 | 0.04 | 0.053 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
37.63%
-3.164
|
-2.299 | -2.426 | -2.049 | -2.055 |
| Basic Average Shares |
0.01%
13.79
|
13.79 | - | 10.99 | 10.17 |
| Diluted Average Shares |
0.01%
13.79
|
13.79 | - | 10.99 | 10.17 |
| Basic Earnings Per Share |
35.29%
-0.23
|
-0.17 | - | -0.19 | -0.20 |
| Diluted Earnings Per Share |
35.29%
-0.23
|
-0.17 | - | -0.19 | -0.20 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):